CRP and type 1 diabetes mellitus: Even though the between-group differences in CRP in the present study were small, and CRP has been used as a consistent marker for evaluating the extent of cardiovascular diseases in subjects with type 1 diabetes [66-70], we suggest that others determinants, such as genetic predisposition, coping mechanisms, and environmental factors, make individuals more susceptible to changes in this inflammatory marker.